De Novo pathway

Regulatory Review Timelines for Medical Devices

by
Regulatory review timelines for medical devices and FDA approval pathways

Regulatory review timelines for medical devices in 2026 remain a critical determinant of commercialization strategy in the United States. Device manufacturers must navigate a structured but evolving framework governed by the Food and Drug Administration, where review speed is influenced by device classification, submission pathway, and data quality. As innovation accelerates across digital health, diagnostics, … Read more

US Medical Device Classification System Overview

by
US medical device classification system overview and FDA regulatory pathways

The US medical device classification system is a foundational regulatory framework that determines how medical devices are evaluated, approved, and monitored before entering the market. Overseen by the Food and Drug Administration, this system categorizes devices based on risk, intended use, and level of control required to ensure safety and effectiveness. For manufacturers, investors, and … Read more